Invention Grant
- Patent Title: In vitro and cell based assays for measuring the activity of botulinum neurotoxins
-
Application No.: US16343513Application Date: 2017-10-19
-
Publication No.: US11306347B2Publication Date: 2022-04-19
- Inventor: Min Dong , Feifan Yu
- Applicant: President and Fellows of Harvard College
- Applicant Address: US MA Cambridge
- Assignee: President and Fellows of Harvard College
- Current Assignee: President and Fellows of Harvard College
- Current Assignee Address: US MA Cambridge
- Agency: Choate, Hall & Stewart LLP
- Agent Brenda Herschbach Jarrell; Stephanie L. Schonewald
- International Application: PCT/US2017/057411 WO 20171019
- International Announcement: WO2018/075783 WO 20180426
- Main IPC: C12Q1/66
- IPC: C12Q1/66 ; C12N9/02 ; C12N9/24 ; C12N9/52 ; G01N33/542

Abstract:
Disclosed herein are means for the detection and characterization of neurotoxins such as botulinum neurotoxin (BoNT) or tetanus neurotoxin. The present disclosure provides methods for determining potency and activity of neurotoxins in vitro and in vivo. Also disclosed are polypeptides comprising N- and C-terminal fragments of a reporter protein that are split by a linker comprising a neurotoxin cleavage site. Cleavage of the linker by a neurotoxin decreases reporter protein activity, thereby indicating activity of the neurotoxin. Compositions and kits comprising the disclosed polypeptides, nucleic acids comprising nucleotide sequences encoding such polypeptides, and cells expressing such polypeptides are also disclosed.
Public/Granted literature
- US20190276873A1 IN VITRO AND CELL BASED ASSAYS FOR MEASURING THE ACTIVITY OF BOTULINUM NEUROTOXINS Public/Granted day:2019-09-12
Information query